Pelthos Therapeutics
Price & Volume
Stats
See more52W Range | $18.19-$37.50 |
Market Cap | $83.8M |
Shares Short | 104,324 |
Financials
See moreRevenue (12 Mos) | $43.3M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $32.7M |
Diluted EPS | -$28.63 |
News
See moreYahoo Finance • last month
This Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone
Yahoo Finance • 3 months ago
Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes
Yahoo Finance • 5 months ago
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
Yahoo Finance • 5 months ago
Pelthos Therapeutics Announces CFO Transition
About
CEO | Mr. Scott M. Plesha |
CFO | Mr. John M. Gay CPA |
Address | 4020 Stirrup Creek Drive, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 92 |